[DOI] [PubMed] [Google Scholar] 68.Baggio LL, Drucker DJ
The GLP-1 market, dominated so far by pharmaceutical giant Novo Nordisk, has faced supply constraints in recent months as the drugs get expanded approval from health regulators and increased health coverage
Comparative effectiveness of dulaglutide versus liraglutide in Asian type 2 diabetes patients: a multi-institutional cohort study and meta-analysis
Aristizbal-Colorado, D., Corredor-Rengifo, D., Sierra-Castillo, S., Lpez-Corredor, C., Vernaza-Trujillo, D
It was approved by the US Food and Drug Administration (FDA) as a 2-line drug for T2DM patients in 2005, and was marketed in China in 2009
Kind Patches, a popular brand on TikTok, has renamed its GLP-1 patches as berberine patches, though the formula remains the same, according to its website